Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Clinical & Experimental Optometry|July 22, 2014
Is screening for congenital colour vision deficiency in school students worthwhile? A reviewNishanthan Ramachandran, Graham A Wilson, Nick Wilson
Clinical & Experimental Ophthalmology|January 30, 2004
Retinoblastoma, microphthalmia and the chromosome 13q deletion syndromeGraham A Wilson, Angele Devaux, Maryam Aroichane
Archives of Ophthalmology (Chicago, Ill. : 1960)|July 6, 2002
The big brown eyes of Samuel PepysGraham A Wilson, Amanda P Field, Susannah Fullerton
The New Zealand Medical Journal|August 15, 2009
Acute infective conjunctivitis: evidence review and management advice for New Zealand practitionersGenevieve F Oliver, Graham A Wilson, Richard J Everts
The New Zealand Medical Journal|July 9, 2021
Impact of the COVID-19 pandemic lockdown on public sector ophthalmic work by New Zealand's ophthalmologistsDaniel A R Scott, Peter W Hadden, Graham A Wilson
Archives of Ophthalmology (Chicago, Ill. : 1960)|September 14, 2011
Identification of variants in CNGA3 as cause for achromatopsia by exome sequencing of a single patientKevin Lam, Haiyan Guo, Graham A Wilson, et al.
Clinical & Experimental Ophthalmology|September 8, 2017
Diabetic retinopathy screening using deep neural networkNishanthan Ramachandran, Sheng Chiong Hong, Mary J Sime, et al.
Clinical & Experimental Ophthalmology|September 9, 2020
Proof-of-concept calculations to determine the health-adjusted life-year trade-off between intravitreal anti-VEGF injections and transmission of COVID-19Matt J Boyd, Daniel A R Scott, David M Squirrell, et al.
The Ocular Surface|August 18, 2020
Characterising the ocular surface and tear film in a population-based birth cohort of 45-year old New Zealand men and womenJennifer P Craig, Michael T M Wang, Antony Ambler, et al.
American Journal of Preventive Medicine|June 26, 2025
Persistent Cannabis Use and Ocular Health in MidlifeKirsten Cheyne, Rachael L Niederer, Antony Ambler, et al.
Pageof 3